Previous 10 | Next 10 |
home / stock / ipatf / ipatf news
Immunoprecise Antibodies Ltd. ( OTCPK:IPATF ): Q2 GAAP EPS of -C$0.02. More news on: Immunoprecise Antibodies Ltd., Earnings news and commentary, , Read more ...
Immunoprecise Doubles Q2 Revenue From Q2 2017 Canada NewsWire VICTORIA, Dec. 31, 2018 VICTORIA , Dec. 31, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "ImmunoPrecise") (TSX VENTURE: IPA) (OTC PINK: IPATF) today reports its financial results for Q2 end...
ImmunoPrecise Hires Jason Orloske as Vice President Operations Canada NewsWire VICTORIA, Dec. 26, 2018 VICTORIA , Dec. 26, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce Jason Orlo...
ImmunoPrecise Announces Results of Annual General Meeting Canada NewsWire VICTORIA, Nov. 21, 2018 VICTORIA , Nov. 21, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that all resolutions were passed by ...
ImmunoPrecise Antibodies Ltd. Announces Genetic Immunization Platform Canada NewsWire VICTORIA, Oct. 29, 2018 Closes Conversion of $1.377 Million of Debentures VICTORIA , Oct. 29, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA)...
ModiQuest to Offer Ligand's OmniAb Service in Europe Canada NewsWire VICTORIA, Oct. 15, 2018 VICTORIA , Oct. 15, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) announces that ModiQuest ® Research, an ImmunoPr...
ImmunoPrecise Signs Large Pharma Antibody Development Agreement Canada NewsWire VICTORIA, Oct. 9, 2018 VICTORIA , Oct. 9, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce that it has signed an ...
ImmunoPrecise Announces Phage Display-Based Antibody Discovery Platforms Canada NewsWire VICTORIA, Oct. 2, 2018 VICTORIA , Oct. 2, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) announced the addition of in-ho...
ImmunoPrecise Antibodies' Q1 Revenues Increase 386% Over Q1 2017 Canada NewsWire VICTORIA, Oct. 1, 2018 VICTORIA , Oct. 1, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise") (TSX Venture: IPA) (Pink Sheets: IPATF) today reports its financial results for Q...
ImmunoPrecise Closes Oversubscribed Private Placement Raising $9.1M Canada NewsWire VICTORIA, Sept. 28, 2018 VICTORIA , Sept. 28, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) announces that it has closed its ...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPATF Stock Symbol:
OTCMKTS Market:
ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock Exchange Canada NewsWire VICTORIA, BC , Dec. 23, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (Nasdaq Global Markets: IPA), a leader in full-service, therapeu...
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal Year Canada NewsWire Record Quarterly Revenue of $4,754,545 and Adjusted EBITDA of $795,159 Announced Strategic Partnership ...
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate VICTORIA, BC , Dec. 14, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. ("IPA") (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody discovery and development and LiteVax...